IDO1 and neoplasm: designed a dual-functional drug conjugate comprised of protoporphyrin IX and NLG919, a strong indoleamine-2,3-dioxygenase (IDO) inhibitor, to enhance the biocompatibility and tumor accumulation of the drug conjugate (PpIX-NLG@Lipo) (Figure 4A).